Hillhouse Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Hillhouse Investment Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-949,431	Closed	-$49.6M	–	40
2018 Q3	$49.6M	Buy	949,431 +250,000	+36%	+$13.6M	1.33%	18
2018 Q2	$30.4M	Hold	699,431	–	–	0.52%	28
2018 Q1	$25.9M	Buy	699,431 +249,431	+55%	+$6.66M	0.46%	27
2017 Q4	$8.93M	Hold	450,000	–	–	0.15%	37
2017 Q3	$11.2M	Hold	450,000	–	–	0.19%	36
2017 Q2	$7.85M	Buy	+450,000	New	+$7.87M	0.12%	42

Other funds holding GTHX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hillhouse Investment Management's GTHX Position: Q4 2018 in Review

Hillhouse Investment Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2018, closing a stake of 949,431 shares — an estimated $49.6M sold.

Hillhouse Investment Management first reported a position in GTHX in Q2 2017 and held it in 6 quarters. The position peaked at $49.6M in Q3 2018. 93 funds tracked by Wall St. Rank hold GTHX as of Q4 2018.

Hillhouse Investment Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Hillhouse Investment Management sold 949,431 G1 Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $49.6M.
Hillhouse Investment Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2017 and held it in 6 quarters.
Hillhouse Investment Management's G1 Therapeutics, Inc. Common Stock position peaked at $49.6M in Q3 2018.
93 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Hillhouse Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.